Causes of Hypercalcemia
The most common causes of hypercalcemia are primary hyperparathyroidism and malignancy, which together account for approximately 90% of all cases. 1 Understanding the underlying etiology is crucial for appropriate management and treatment.
PTH-Dependent Causes
Primary hyperparathyroidism: Most common cause overall, characterized by elevated or inappropriately normal PTH levels 2
- Typically due to parathyroid adenoma, hyperplasia, or rarely carcinoma
- Often presents as mild, asymptomatic hypercalcemia
Tertiary hyperparathyroidism: Occurs in chronic kidney disease patients after prolonged secondary hyperparathyroidism 3
- Results from autonomous parathyroid function after long-standing renal disease
Familial hypocalciuric hypercalcemia: Genetic disorder with mutation in calcium-sensing receptor 4
- Characterized by high calcium, normal/high PTH, and low urinary calcium excretion
Lithium therapy: Causes hypercalcemia by reducing calcium-sensing receptor sensitivity in parathyroid glands 5
PTH-Independent Causes
Malignancy-Related
Humoral hypercalcemia of malignancy: Mediated by PTHrP production 2
- Common in squamous cell carcinomas of lung, head and neck, renal cell carcinoma, ovarian cancer
- Often occurs with minimal or no bone metastases
Local osteolytic hypercalcemia: Due to direct bone invasion 2
- Common in breast cancer and multiple myeloma
- Mediated by local cytokine production that stimulates osteoclasts
1,25-dihydroxyvitamin D production: Seen in some lymphomas 2, 4
Medication-Induced
- Thiazide diuretics: Reduce urinary calcium excretion 5
- Vitamin D toxicity: Excessive supplementation or treatment 2
- Vitamin A excess: Increases bone resorption 1
- Calcium supplements: Especially with milk-alkali syndrome 4
- Denosumab discontinuation: Rebound hypercalcemia after stopping therapy 1
- Sodium-glucose cotransporter 2 inhibitors: Rare cause 1
- Immune checkpoint inhibitors: Emerging cause in cancer immunotherapy 1
Other Causes
Granulomatous disorders: Including sarcoidosis, tuberculosis 2
- Increased 1,25-dihydroxyvitamin D production by activated macrophages
- Requires measurement of both 25-OH and 1,25-OH2 vitamin D levels
Endocrine disorders:
- Thyrotoxicosis: Increases bone turnover 5
- Adrenal insufficiency: Alters calcium homeostasis
Immobilization: Particularly in patients with high bone turnover 1, 6
- Common in young patients with paralysis or prolonged bed rest
Williams syndrome: Idiopathic infantile hypercalcemia 3
- Presents with irritability, vomiting, constipation, muscle cramps
- Usually resolves during childhood but may persist
Severe acute illness: Including SARS-CoV-2 infection (rare) 1
Diagnostic Approach
Initial laboratory evaluation: Complete blood count, renal function, albumin, phosphorus, magnesium 2
- Calculate corrected calcium if albumin is abnormal:
- Corrected calcium (mg/dL) = Total calcium (mg/dL) + 0.8 × [4 - Serum albumin (g/dL)] 3
Measure intact PTH level: Critical for differentiating causes 2, 1
- Elevated/normal PTH → PTH-dependent causes (primarily hyperparathyroidism)
- Suppressed PTH (<20 pg/mL) → PTH-independent causes (malignancy, vitamin D toxicity)
Additional testing based on clinical suspicion:
- PTHrP for suspected malignancy
- Vitamin D metabolites (25-OH and 1,25-OH2) for suspected granulomatous disease or vitamin D toxicity
- Urinary calcium for familial hypocalciuric hypercalcemia
- Serum protein electrophoresis for multiple myeloma
Clinical Pitfalls to Avoid
- Failing to correct calcium for albumin: Total calcium may not reflect true hypercalcemia in hypoalbuminemic states 3
- Overlooking medication causes: Always review medication list, including supplements 2
- Treating the laboratory value without addressing underlying cause: Essential to identify and treat the primary etiology 2
- Missing familial hypocalciuric hypercalcemia: Can be mistaken for primary hyperparathyroidism but does not require parathyroidectomy 4
- Delaying treatment of severe hypercalcemia: Life-threatening hypercalcemia requires prompt intervention regardless of diagnostic workup completion 7
Remember that while primary hyperparathyroidism often presents as mild, chronic hypercalcemia, malignancy-associated hypercalcemia typically develops more rapidly and may be more severe, requiring urgent intervention 1, 7.